Buprenorphine 101: Physicians and Community Pharmacists Collaborating to Improve Access to Medication Assisted Treatment

Registration is a 2-step process! 

Select 'ENROLL NOW' to register and gain access to the link that will allow you to complete part 2 of the 2-step registration process.

Wednesday, October 30, 2019 (3:00PM - 4:00PM ET)

Pre-registration is required to participate.

Activity Preview

Buprenorphine is an evidence-based therapy used in medication assisted treatment (MAT) for opioid use disorder (OUD).  Many barriers exist to expanding patient access to buprenorphine, and national efforts are underway to educate health care practitioners, including pharmacists about the appropriate use of buprenorphine. This webcast, conducted in collaboration with the American Society of Addiction Medicine, will pair a physician specialist with a community pharmacist to provide an in-depth overview of buprenorphine for MAT, describe barriers to the provision of buprenorphine for MAT in community pharmacies, and discuss ways that community pharmacists can contribute to expanding access to buprenorphine for MAT.    

Learning Objectives

At the completion of this activity, the participant will be able to:

  1. Discuss the clinical approach to using buprenorphine for MAT.  
  2. Describe the differences between buprenorphine products for MAT and those for pain.  
  3. Identify barriers to pharmacist dispensing buprenorphine for MAT and effective strategies in overcoming those barriers.  
  4. Discuss effective approaches for physicians and community pharmacists to collaborate in ensuring access to MAT. 

Activity type: Knowledge-based

Target Audience: Pharmacists 

Learning level: 1

Accreditation Information (Pharmacists)

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity is approved for 1.0 contact hours of CPE credit (0.10 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-285-L01-P.

To obtain credit for Buprenorphine 101: Physicians and Community Pharmacists Collaborating to Improve Access to Medication Assisted Treatment, complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted.  The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial release date: October 30, 2019
Expiration date for LIVE credit: December 30, 2019 - NO CREDIT GRANTED AFTER THIS DATE

Accreditation Information (Physicians)

   The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Addiction Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit (s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Initial release date: October 30, 2019
Expiration date for LIVE credit: December 30, 2019 - NO CREDIT GRANTED AFTER THIS DATE

Development

Buprenorphine 101: Physicians and Community Pharmacists Collaborating to Improve Access to Medication Assisted Treatment is a live continuing education activity for pharmacists developed by the American Pharmacists Association in conjunction with the American Society of Addiction Medicine.

Support

This webinar is supported by an educational grant provided by the Opioid Response Network.

Disclosures

Shawn A. Ryan, MD, MBA, ABEM, ABAM, Olivia Kinney, PharmD, and APhA’s Government Affairs and editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.

Fee

There is no fee associated with this activity.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website and view the Technology System Requirements to have a positive learning experience.

Buprenorphine 101: Physicians and Community Pharmacists Collaborating

Date 10/30/2019 3:00:00 PM
Address 2215 Constitution Ave
City NW State District of Columbia Zip Code 20037